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Provision of Survivorship Care Plans in                   
Hard-to-Reach Patient Populations 
 
 
More Americans are surviving cancer than ever before due to 
advancements in cancer treatment and research. As of January 1, 2016, 
there were more than 15.5 million children and adults with a history of 
cancer living in the United States.1 That number is estimated to reach 
approximately 20.3 million by January 1, 2026.1 Conversely, cancer death 
rates have declined 26 percent since a peak in 1991.2 Rates of five-year 
cancer survival for the most common types of cancer combined have been 
improving, increasing from 50 percent in 1975 to 66 percent in 2012.3 With 
increases in the five-year survival rate, a focus on long-term survivorship 
care is of critical importance, now more than ever before.   
 
Long-term survivorship care emphasizes quality, consistency, and 
advocacy for best care practice in four general areas: disease surveillance, 
recognition of cancer recurrence, ensuring adherence with healthcare 
maintenance, and education of the possible late- and long-term effects of 
cancer therapy. In order to help survivors make a successful transition to 
post-treatment cancer survivorship and enable them to actively 
communicate and engage with their providers in these four areas, the 
Institute of Medicine recommended the development and use of 
survivorship care plans (SCPs).4  
 
A 2005 Institute of Medicine report, “From Cancer Patient to Cancer 
Survivor: Lost in Transition”, recommended that each survivor receive a 
SCP to improve quality of life. The SCP is an individualized record that 
summarizes and communicates what transpired during active cancer 
treatment regarding the patient’s diagnosis and treatment. Additional 
content includes: potential late- and long-term effects of cancer therapy; 
signs of cancer recurrence; instructions for the recommended follow-up, 
physical examinations, cancer surveillance, and diagnostic testing 
schedules; education and promotion of healthy lifestyle behaviors for 
prevention of secondary malignancies; and resources and referrals to 
support services. A SCP is therefore considered a tool that may equip 
survivors with the knowledge and skills required for management of 
The Case for 
Survivorship 
Care Plans 
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potential physical, psychological, and social needs post-treatment.  
  
The Commission on Cancer (CoC) of the American College of Surgeons has 
played an integral role in setting the stage for SCP delivery. The American 
College of Surgeons, founded in 1913, is a consortium of professional 
organizations that utilizes standard setting to improve survival and quality 
of life for cancer patients.5 The first set of standards was published in 1930, 
and later established into an Approvals Program (now Accreditation 
Program) that evaluates cancer clinic’s performance against the standards. 
CoC accreditation is granted to facilities that are committed to providing 
the best in cancer care while demonstrating compliance with CoC 
Eligibility Requirements and Standards. To maintain accreditation, cancer 
programs must undergo an on-site review every three years. Currently, 
CoC Accredited Programs encompass more than 1,500 hospitals, 
freestanding cancer centers, and cancer program networks in the United 
States and Puerto Rico.5 
 
In 2015, the CoC implemented standard 3.3 to facilitate implementation of 
SCPs in cancer treatment centers. Standard 3.3 requires cancer survivors be 
provided with a comprehensive treatment summary and SCP, and further 
outlines the timelines, guidelines and standards regarding SCP delivery.  
 
Figure 1. Excerpt from the 2016 CoC Standards Manual 5 
 
Accreditation 
Standards for 
Survivorship 
Programs 
Cancer programs are required to develop and implement processes to 
monitor the formation and dissemination of SCPs for analytic cases with 
Stage I, II, or III cancers that are treated with curative intent for initial 
cancer occurrence and who have completed active therapy. The printed or 
electronic survivorship care plan must contain input from the principal 
physician and oncology care team who coordinated the oncology 
treatment for the patient, as well as input from the patient’s other care 
providers (outside treatment information), if applicable. If two separate 
facilities are providing treatment, both facilities collaborate to complete 
and provide the SCP. In all cases, programs, hospitals, and physician 
offices should work together to provide the information necessary for 
completion of a SCP that contains all required elements. 
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To meet standard 3.3, the SCP must be provided within one year of the 
cancer diagnosis (or 18-months for patients receiving long-term hormonal 
therapy), and within six months after completion of adjuvant therapy 
(other than long-term hormonal therapy). Patients with Stage 0, IV, or 
metastatic cancer are excluded from the SCP provision requirement. 
Patients who are seen by an accredited program only for pathological 
diagnosis, and are not treated or provided follow-up care by the program, 
are not required to receive a SCP from the facility providing only a 
diagnosis. The standard also outlines that the SCP should be discussed 
with the patient, not simply provided by mail, electronically, or through a 
patient portal. Delivery of the SCP must be recorded in the patient medical 
record.  
 
To maintain accreditation in 2018, programs must provide SCPs to ≥50 
percent of eligible patients who have completed treatment. During the 
implementation period of standard 3.3 (January 1, 2015 – December 31, 
2018), the CoC specifies that cancer programs may choose to initially 
concentrate on their most common cancer sites while demonstrating 
progress on expanding SCP delivery to eligible patients for all disease 
sites. For example, many cancer centers began trial delivery of SCPs 
among their eligible breast cancer survivor population and later expanded 
the process into gynecological cancers, head and neck cancers and so on 
until SCP templates existed for all cancers deemed curable. Utilization of a 
staged implementation process for SCP delivery allowed many cancer 
treatment centers to incrementally reach the accreditation standard of 
providing ≥50 percent of eligible patients who have completed treatment 
with a SCP. Across the country, cancer programs are diligently working to 
achieve and maintain standard 3.3 by incorporating SCPs as a standard of 
care. However, for some CoC accredited cancer programs, implementation 
in hard-to-reach populations remains a struggle.  
 
Survivors are typically identified for SCP provision through the health 
systems’ tumor registry, individual patient pathology reports, and through 
tracking by patient navigators. This determines the analytic case load and 
the eligible denominator for SCP provision. Tumor registries track all 
patients with a cancer diagnosis who receive care of any type at the health 
system. 
  
Complications in identifying cancer survivors for SCP provision can arise 
when surgery privileges are granted to private providers outside of a 
Hard to Reach 
Patient 
Populations 
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health system. A cancer patient may have surgical oncology care 
performed by a private provider with surgical privileges at a health system, 
but receive the remainder of their treatment and follow-up care outside of 
that health system’s cancer treatment center. As the surgery took place at 
the health system, these patients are subsequently included in the eligible 
analytic case load. The patient is then included in the denominator of 
eligible survivors for SCP receipt within the health system, despite not 
being a patient of the health system. As such, many of these patients are 
hard to reach for SCP provision and discussion, as the remainder of their 
care occurs outside of the cancer treatment center model. 
 
This white paper highlights the unique collaboration of two individual 
health system cancer treatment centers with one auxiliary specialty center 
as they addressed provision of SCPs in a hard-to-reach patient population 
of urological cancer survivors, including surgery-only prostate patients, 
receiving care outside of a cancer treatment center model.    
 
This project used an observational qualitative design. Key personnel for 
SCP provision at each health system were interviewed, using a structured 
guide.  
 
Participants 
Two health systems and one auxiliary specialty center agreed to share their 
stories of collaboration. A description of the associated facilities and the 
associated cancer center(s) is as follows: 
 
 Avera Health includes the Avera Cancer Institute (ACI), which 
provides comprehensive cancer care at six regional cancer centers 
and 40 outreach sites in SD and surrounding states. Four CoC 
accredited cancer centers, located in the SD cities of Sioux Falls, 
Aberdeen, Mitchell, and Yankton, are partners in the South Dakota 
Survivorship Program. The Sioux Falls location is accredited as a 
comprehensive community cancer program by the CoC. The other 
three rural sites are accredited as community cancer programs.  
 Sanford Health operates four CoC accredited cancer centers in a 
three state area. The Sanford Cancer Center (SCC) in Sioux Falls is a 
partner in the South Dakota Survivorship Program and is accredited 
by the CoC as an academic comprehensive cancer program. SCC 
became a National Cancer Institute’s (NCI) National Community 
Cancer Centers Program partner site in 2007. In 2014, the NCI 
Methods 
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Community Oncology Research Program (NCORP) replaced the 
NCCCP, and SCC remains actively involved. SCC is also certified by 
the Quality Oncology Practice Initiative (QOPI). 
 Urology Specialists Chartered Ambulatory Surgical Center, LLC is 
accredited by the Accreditation Association for Ambulatory Health 
Care (AAAHC).  
 
Interview Questions 
A structured interview guide was developed to gather information 
describing the models of collaboration between the cancer treatment 
centers and the auxiliary specialty center. To explore the processes, 
challenges, and successes of collaboration, this paper assessed the 
following questions among the interviewed facilities: 
 
1. How does cancer survivorship fit into the mission of your health 
system? 
2. Tell us a little about your survivorship program and how that is 
currently set up and administered. 
3. When did you begin your collaboration with Urology Specialists? 
4. Would you describe for us the factors or the context that led you to 
reach out to this population? 
5. What has happened to date? 
6. What urological cancer patients are currently provided with 
survivorship services as part of your health system’s collaboration 
with Urology Specialists? Is it just prostate so far, or is their SCP 
provision for bladder and urethral cancers, kidney cancer, penile 
cancer and testicular cancer as well? 
7. How are surgery only prostate patients identified for survivorship 
care plan provision? 
8. According to CoC Standard 3.3, if two separate facilities are 
providing treatment, both facilities must collaborate to complete 
and provide the SCP. How does this process work for prostate 
patients and your partnership with Urology Specialists? 
9. How do navigators access patient information to complete the SCP? 
10.  Tell us about the timing and method(s) of delivery of survivorship 
care plans for prostate patients (mailed SCP accompanied by phone 
visit / full survivorship visit).  
11.  Who has oversight responsibility for the survivorship navigators 
working with Urology Specialists and how was this decided? 
12.  What resources are provided by each facility to support this role? 
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13.  Does your organization bill for any of the urology survivorship 
services? If so, how is this time or visit billed? Do other funding 
mechanisms support this service / navigator? 
14.  Tell us about the benefits and risks associated with utilizing a 
shared navigator role. 
15.  Are post-treatment services (medical follow-up care, psychosocial 
services, educational opportunities / resources) provided by either 
facility for these patients? If yes, please describe these services? 
How is that decided? 
16.  What lessons have been learned throughout this partnership? 
17.  How can this process facilitate other health systems? 
18.  What hard-to-reach populations remain that are currently not 
receiving SCPs? 
19.  Is there a similar approach that could be utilized to reach those 
populations? 
20.  What else do you think would be important for us to know about 
the partnership between your health system and Urology 
Specialists?  
 
Survivors of urological cancer, including bladder, urethral, kidney, penile, 
prostate, and testicular cancer, approach 6.5 million in number.1 Prostate 
cancer survivors alone represent one in five of all cancer survivors in the 
United States.6 The majority (91 percent) of prostate cancers are 
discovered at a local or regional stage, for which the five-year relative 
survival rate approaches 100 percent and the ten-year survival rate for all 
stages combined is 98 percent.2 Prostate cancer has one of the most 
encompassing inventories of adverse long-term and late effects of the 
disease and its treatment, including urinary incontinence, sexual 
dysfunction, bowel dysfunction, fatigue, pain, and adverse psychosocial 
and relationship effects. Additionally, the long-term health-related effects 
of treatment for patients with localized prostate cancer are found to 
continue more than ten years after treatment.7 Beyond provision of high-
quality surgery or radiation, it is imperative for clinicians to provide high-
quality survivorship care to prostate cancer survivors. In the following 
narrative, we’ll take a look at how local health systems collaborated with a 
center specializing in urology (here forth referred to as the specialty center) 
to improve their quality of care and patient experience.  
 
The specialty center’s mission is to provide comprehensive, 
compassionate, and patient-centered care. Administration realized that 
Models of 
Collaboration 
to Reach 
Survivors of 
Urological 
Cancers 
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cancer survivorship plays an integral part in being able to carry out that 
mission, especially for patients facing an arduous list of adverse effects 
from treatment. The practice felt strongly that it would be beneficial for 
the patient and their primary care provider to receive a summary of their 
cancer treatment, potential long-term and late effects from the cancer and 
its treatment, and recommendations for future follow-up and testing.  
 
Since the private providers at the specialty center maintain surgery 
privileges at local health systems, their patients may receive surgery-only 
treatment, such as radical prostatectomy, at their preference of health 
system. Often, these patients receive the remainder of their care at the 
specialty center. The following models of collaboration present successful 
methods for accessing a hard-to-reach patient population for provision of 
SCPs. 
 
The first health system and specialty center collaboration for survivorship 
began in 2013. The survivorship collaboration was built off of an existing 
working agreement between the two partners based on surgical privileges 
for specialty center private providers, which in turn helps the health system 
build relationships for referrals with patients requiring more advanced 
treatment. The specialty center has ten private providers with surgical 
privileges at the health system. Each month, roughly 30-60 patients are 
connected from the specialty center to the health system for surgery 
alone, or, for some (approximately 10-15 percent), a combination of 
surgery and more advanced cancer treatment (e.g., radiation or 
chemotherapy). For surgery-only patients, follow-up care is provided by 
the specialty center. However, because the surgery took place at the health 
system, the patient is thus included in the denominator population for SCP 
provision to meet accreditation standard 3.3. Seeing a gap in SCP 
provision to this unique population, a strategic decision was made by the 
health system to offer dedicated resources to provide care to this patient 
population that might not receive any direct or additional services from 
the health system other than serving as the location where the patient’s 
private provider performed the surgical removal of their cancer.  
 
The two facilities determined the best way to serve this shared patient 
population would be through hiring a genitourinary (GU) oncology nurse 
navigator to provide patient navigation services, SCP creation and delivery, 
Model #1 
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and recommendations for follow-up care. Although designed around 
survivorship care, the GU navigator’s role is more than just delivery of the 
SCP. The GU navigator position is employed and supported financially 
through the health system to provide the full continuum of cancer services 
in accordance with their mission. As a navigator, this individual is available 
to provide information to help the patient understand their treatment 
options, follow-up with the provider(s), outline future screening needs, and 
address ongoing care questions. In the course of treatment, the navigator 
is given the opportunity to visit with the patient face-to-face at the 
specialty center. The navigator participates in “option talks”, a conversation 
with the care team and the patient to discuss all of the surgical and 
treatment options to decide which treatment is best for the patient. The 
patient is also given written information about all of the different options. 
Early on in the position, this was a way for the GU navigator to get 
information about the treatment decision process from both the patient 
and provider perspective. Now, however, unless it is a complex case, the 
navigator doesn’t typically participate in this initial visit. Currently, the GU 
navigator meets with approximately 75 percent of patients during their 
post-operative stay in the hospital (which typically lasts 36 hours). If the 
navigator is not able to meet with the patient during their post-operative 
stay, or if the diagnosis is not clear during this period, then a survivorship 
visit will take place at the patient’s six-week follow-up appointment or by 
phone after the SCP has been mailed to the patient’s residence. In-person 
delivery is the preferred method, according to received patient feedback. A 
copy of the patient’s SCP is then stored within all three facility EHR 
systems.  
 
Throughout the collaboration, the navigator has found success by having a 
physical presence at the specialty center. Availability on-site has allowed 
the navigator to build relationships with staff that have developed trust in 
the role. The navigator stated the importance of being present, helping 
out even if it isn’t a task within the role, answering questions, and being 
sensitive in relation to who is providing care in each context. A self-
directed nature is required for success of this role. 
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The GU navigator has access to three individual EHR systems, including the 
health system’s EHR, the EHR utilized by the health system’s cancer 
treatment centers, and the specialty center’s EHR. The GU navigator, 
however, must be onsite at the specialty center to access the EHR due to 
technology security protocols dictated by the health system. Thorough 
review of all EHR documentation is required in the development of a 
single SCP, requiring 15-60 minutes per patient. The specialty center 
provides the navigator with access to the same records the physician has, 
and the documentation from the patient’s chart is used to define and 
support the care plan. 
 
Management of the GU navigator position is unique, as the individual 
technically works for both facilities that each have their own set of 
expectations. For this reason, a healthy working relationship between 
facilities is required. Although the navigator is an employee of the health 
system and the supervisor is located at the health system, the navigator 
spends the majority of time at the specialty center in order to have access 
to all three EHRs. The collaboration requires flexibility to allow the 
employee to travel between physical locations as needed.  
 
The shared GU navigator position provides benefits to both facilities. 
Although the financial responsibilities fall onto the health system, the 
benefit of accessibility to the GU patients who may otherwise be hard to 
reach is of tremendous value, as provision of SCPs to this population helps 
the health system reach the CoC accreditation requirement of SCP 
provision to ≥50 percent of eligible patients who have completed 
treatment. Additionally, the health system credits the GU navigator for 
building trust with the private providers at the specialty center and 
allowing them to feel more comfortable referring their patients back to the 
health system if more advanced treatment is required. Since these are 
private provider patients, the health system chosen for surgery is based on 
both the patient and private providers’ choice. The presence of a GU 
navigator from the health system, and development of positive 
relationships can help persuade patients and providers to choose the 
health system for their surgery. This benefit alone outweighs the cost of 
providing the resources to fund the GU navigator role - the money is 
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invested up front in hopes of a long-term gain. Most importantly, the 
service fits with the mission of the health system in providing the best care 
to patients and, as stated by health system staff, “is just the right thing to 
do”. Overall, the health system sees the value in strengthening their 
standard of practice by offering navigation services, SCP delivery, and 
follow-up care recommendations to all patients associated with the health 
system, even if that association is by surgery alone.  
 
For the specialty center, the benefits of providing working space and EHR 
access to the GU navigator are many. The specialty center is able to support 
their mission of providing comprehensive, compassionate, and patient-
centered care through this collaboration, as well as enhance the patient 
experience. Outside of EHR access and provision of and working 
accommodations to include computer, printer, paper, postage and other 
office supplies for the shared GU navigator role, the service is essentially free 
of cost for the specialty center, and becomes an asset with the potential to 
market these services to prospective patients.  This is currently a free service 
to the patient as neither facility bills for the GU navigator’s time. 
 
Management at the health system identified that the nature of the person 
in the navigator role is key, regardless of how the partnership is set up. A 
large part of the success is having the right person in the position. It is a 
tough role managing expectations of two unique facilities in addition to 
patient expectations, and it requires someone with a leadership 
background to be successful in such a self-directed position.  
 
Opportunities exist to expand the comprehensiveness of the services 
offered through this collaboration and possibly expand this same model to 
other hard-to-reach patient populations. Patients at the health system 
have access to a wealth of resources, including a social worker and 
chaplain to meet some of their psychosocial needs. The shared patients in 
this collaboration with the specialty center do not yet have access to this. 
The same model could be used in other population gaps, such as 
dermatology patients, head and neck cancers, and breast cancer patients 
receiving surgery only from an outside provider, with the understanding 
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that it takes time and patience to build a successful collaborative 
relationship.  
 
The second model of collaboration for survivorship care was initiated in 
May 2017 between the specialty center and another health system. The 
mission of the collaborating health system is dedicated to the work of 
health and healing. Survivorship fits into the mission as it is really the 
transition of healing to the next step of general health and well-being, 
with a focus on diet, exercise, and holistic well-being. Discussions began in 
February 2015 on the topics of survivorship care and collaboration for 
clinical research trials between the facilities. In March 2015, the health 
system hosted an inservice on survivorship efforts for staff of the specialty 
center. Then, in March 2017, management from both facilities met to 
discuss how to integrate survivorship to benefit both parties. Through the 
health system’s involvement in the South Dakota Survivorship Program, 
funding was provided to support a GU oncology nurse navigator to work 
with surgery-only patients of the specialty center. A GU navigator was 
hired in May 2017 and the position began working with the specialty 
center in June 2017. 
 
The GU navigator provides patient navigation services, SCP creation and 
delivery, and recommendations for follow-up care to patients of the 
specialty center receiving surgery-only treatment at the health system. 
Patients are identified for SCP eligibility through the tumor registry at the 
health system, review of weekly pathology reports, and also through the 
health system navigators. Additionally, schedulers at both the health 
system and the specialty center typically notify the GU navigator of any GU 
patients scheduled for surgery-only cancer treatment at the health system.  
 
Two individual EHR systems are available to the GU navigator, including 
the health system’s EHR (which is the same EHR used by the health 
system’s cancer treatment centers) and the specialty center’s EHR. Travel to 
the specialty center is not required for the development of the SCP as the 
navigator has access to both EHRs on-site at the health system. 
Documentation is pulled from each facilities’ EHR to support the SCP 
development. The care plan then outlines late and long-term side effects 
Model #2 
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from treatment, life after treatment, follow-up care needs and educational 
materials including advance care planning, nutrition, physical activity, and 
psychosocial support. The navigator’s contact information is also provided 
in case the patient has further questions. Utilization of two unique EHRs 
can be time consuming, with development of an SCP requiring 30-45 
minutes for completion. For this reason, access to the specialty center’s 
EHR within the walls of the health system is necessary for successful time 
management. Once an SCP is completed, it is loaded into the health 
system EHR and a copy is shared with the specialty center to be loaded 
into their EHR. 
 
As the GU navigator initially started in the role, visits were scheduled in-
person with the patient to review the SCP and the navigator would make 
frequent trips to the specialty center. The navigator has since decided that 
this was not a valuable use of time, nor was in-person delivery a preferred 
method based on patient feedback. The navigator now spends most of the 
position based at the health system, determining that mailing out the SCP 
and following up with a phone-based visit seems to be the preference of 
most patients. The phone-based visit is resource saving, as it typically 
takes about 15 minutes to review the SCP with the patient. The navigator 
has also noticed that patients tend to be more open to discussing sensitive 
subjects over the phone rather than in person. “Cancer looks different for 
GU patients”, according to the navigator. “Many of the patients don’t even 
see themselves as cancer patients, and therefore, their expectations are 
different.” GU patients often undergo surgery and are essentially cured 
with no further treatment required. These patients are typically treated 
more like surgical patients than cancer patients. The SCP and follow-up 
care instructions are also much less detailed than for other types of cancer. 
The unique setting and patient population makes these survivors more 
difficult to reach. “Not all patients want the conversation” associated with 
the SCP. According to the navigation team, it seems that the less intensive 
treatment for the majority of this population makes them less interested in 
the SCP. However, overall patient feedback on the GU navigation services 
and SCP provision has been positive. 
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Management of the GU navigator position is again unique, as the 
individual technically works for both facilities. Oversight for the position 
comes mainly from the health system, but the navigator also works closely 
with the Nurse Director at the specialty center. The navigator has been 
cautious to be collaborative, without making extra work for the staff of the 
specialty center. The collaboration again requires flexibility to allow the 
employee to travel between physical locations as needed to provide 
services, although for this partnership, most services are provided by 
phone.  
 
The GU navigator position is currently funded through provisions from the 
South Dakota Survivorship Program. However, the health system plans to 
sustain the position beyond the grant funding period, seeing the benefit 
of the role. The specialty center supports the navigator position by 
providing access to their EHR management system and working 
accommodations to include computer, printer, paper, postage and other 
office supplies while on site. There is currently no fee to the patient 
associated with the provided survivorship services. 
 
For the specialty center, the benefits of providing working space and EHR 
access to the GU navigator are the same as previously mentioned: 
supporting their mission and enhancing the patient experience. The 
benefit to the health system is improving the percentage of eligible 
patients that receive a SCP for the CoC accreditation standard. The real 
benefit, however, is for the patient who is now able to receive a SCP and a 
team approach to care.  
 
In order to make the collaboration work, buy-in is required from each 
facility. Private providers need to be supportive of the navigation services, 
and the GU navigator needs to provide high quality services with minimal 
disruption to the private providers and patients. A dedicated site-specific 
navigator is also needed for success. SCP creation is time consuming and 
needs to be individualized for each cancer population. With the 
uniqueness of each population, it takes some time to figure out how to 
enhance the SCP’s impact for the patient.   
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At this health system, opportunities exist and are being explored to 
expand navigation services and SCP provision to patients of dermatology, 
thyroid, and other surgery-only patient populations. Surgical-only patients 
are difficult to identify and reach, whether inside or outside of the health 
system. Patients typically fall into three groups for cancer treatment: 1) 
those receiving care through the standard medical oncology unit, who are 
easy to reach as standard survivorship processes are established, 2) 
surgery-only patients internal to the health system, who are slightly more 
difficult to reach, but processes are being established, and 3) external 
surgery-only patients from specialty private providers, who are very 
difficult to identify, which is why survivorship collaborations with specialty 
providers are a necessity. Every surgery-only cancer type has unique 
challenges, but with patience in process development and site-specific 
training, SCP provision will continue to expand.  
 
Long-term survivorship care is of critical importance as the population 
with a history of cancer, as well as the five-year survival rate, continues to 
increase. Survivorship collaborations with specialty providers can enhance 
care collaborations, as well as enhance the overall patient experience. The 
two health system collaborations outlined above offer unique models of 
partnership for survivorship care provision with a specialty provider to 
access a hard-to-reach population of surgery-only patients.  Each health 
system developed a model of collaboration that fit with the unique needs 
and resources of their health system.  
 
For one health system, the GU navigator’s on-site presence at the specialty 
center was highly valued. The health system credits the navigator’s 
physical presence at the specialty center for the development of trust and 
a mutually beneficial collaboration between the facilities. The navigator 
expressed the importance of being present and available to jump in and 
help out where needed, while remaining sensitive to who is providing care 
in each context. According to this health systems’ received patient 
feedback, in-person delivery and discussion of the SCP is preferred.  
 
In the second model of collaboration, maximizing efficiency within the role 
was highly valued, leading the GU navigator to work mainly from the 
Summary of 
Collaborations 
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health system. The navigator has been cautious to be collaborative, 
without making extra work for the staff of the specialty center. The 
navigator communicates frequently with the Nurse Director and the 
schedulers at the specialty center to identify patients scheduled for 
surgery-only urological cancer treatment at the health system. In this 
health system’s experience, patients prefer to receive their SCP by mail, 
followed by a phone conversation regarding the document. The navigator 
expressed that patients tend to be more open to discussing sensitive 
subjects over the phone rather than in person. 
 
Although the collaboration models vary in delivery methods, both models 
have received positive patient feedback, indicating that the service 
provides value regardless of the method of delivery, and is a good 
investment for the patient’s well-being. In both models of collaboration, a 
self-directed nature is required for success in the GU navigator role. Both 
collaborations also require flexibility in management, allowing the 
employee to travel between physical locations as needed to provide 
services. Due to the uniqueness of the shared role, a healthy working 
relationship and strong communication between facilities is a necessity. 
Both facilities must agree that survivorship care is best for the patient.  
 
The benefits of collaboration on survivorship care efforts are vast. For the 
specialty center, the main benefit of the partnerships is the increased 
capacity to support their mission of providing comprehensive, 
compassionate, and patient-centered care. The specialty center could also 
market the services to prospective patients, supporting an enhanced 
patient experience. No drawback was identified for the specialty center. A 
tremendous benefit of collaboration for the health systems is accessibility 
to the GU patients for provision of SCPs. This helps the health systems 
reach the CoC accreditation requirement of SCP provision to ≥50 percent 
of eligible patients who have completed treatment. Additionally, the 
collaboration helps encourage referrals back to the health systems when 
patients have advanced treatment needs, which helps balance the cost of 
supporting the navigator role. Most importantly, the collaborations help 
support care coordination among facilities and provide a team approach 
to patient care.   
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